New ACC/AHA Aortic Disease Guideline
The newest clinical guideline from the ACC and the American Heart Association (AHA) aims to guide clinicians in the diagnosis and management of patients with aortic disease. Specifically, the 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease provides recommendations regarding diagnosis, genetic evaluation and family screening, medical therapy, endovascular and surgical treatment, and long-term surveillance across multiple clinical presentation subsets, ranging from asymptomatic patients to those with acute aortic syndromes.
Among the highlights, the guideline encourages the use of centers with Multidisciplinary Aortic Teams in determining the appropriate timing of intervention. There is also added emphasis on the role of shared decision-making, especially in the management of patients with aortic disease both before and during pregnancy due to the “cardiovascular risks of pregnancy, the diameter thresholds for prophylactic aortic surgery, and the mode of delivery.” Read more.
To access clinician and patient tools related to the Guideline, including CardioSmart resources and a JACC Aortic Disease Interactive Guideline Tool tied to family screening, visit ACC’s Aortic Disease Guideline Hub.